Gore recently announced the first implantation of the investigational Gore ascending stent graft in the ARISE III trial for the treatment of an acute type A dissection @WLGore https://t.co/qWdvKIOcbh
New 5-year data from the EXCC pivotal trial:
The GORE® EXCLUDER® Conformable AAA Endoprosthesis shows 0% aneurysm-related mortality, no conversions, and no major endoleaks.
Safe. Durable. Effective—regardless of seal zone length. https://t.co/U0lTDy2UJc
Emerging Treatments for Complex Aortic Disease at University Hospitals Harrington Heart & Vascular Institute
@HarringtonHVI
https://t.co/500YH5ZbUo
Today the first total percutaneous 3 vessel Endovascular arch repair of the Americas was done at UT Health Houston - Memorial Hermann Heart and Vascular Institute. Thx for all support from our multi-specialty team, Cook Medical and GE healthcare. New chapter is written in Houston
Fellows, integrated residents, residents: Enhance your education w/training opportunities tailored to your specialty/program & designed to elevate your educational journey. Read more ➡️ https://t.co/VOthu9mOhT #MedEd#CookFellows#Vascular#IReducation#InterventionalCardiology
Today’s endovascular specialists face distinct challenges when treating patients with below-the-knee peripheral arterial disease. Our goal is to serve as a procedural partner by providing physicians w/tools to access, target & treat this complex disease. https://t.co/tkcPTdE989